FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

ZC Han

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Co-author Network

Publications

TOP 3
L Lecomte-Raclet; Mohamed Rholam; M Alemany; Noureddine Lazar; Catherine Simenel; Muriel DELEPIERRE; ZC Han; Paul Cohen; Jacques Caen
Dual structural requirements for multilineage hematopoietic-suppressive activity of chemokine-derived peptides.
Jacques Caen; ZC Han; Sylvia Bellucci; M Alemany
Regulation of megakaryocytopoiesis.
S Aidoudi; M Guigon; V Drouet; Jacques Caen; ZC Han
The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of ZC Han (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: L Lecomte-Raclet; Mohamed Rholam; M Alemany; Noureddine Lazar; Catherine Simenel; Muriel DELEPIERRE; ZC Han; Paul Cohen; Jacques Caen
Dual structural requirements for multilineage hematopoietic-suppressive activity of chemokine-derived peptides.
Biochemistry 2000;39(31):9612-22.
1999: Jacques Caen; ZC Han; Sylvia Bellucci; M Alemany
Regulation of megakaryocytopoiesis.
Haemostasis 1999;29(1):27-40.
1998: S Aidoudi; M Guigon; V Drouet; Jacques Caen; ZC Han
The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo.
International journal of hematology 1998;68(2):145-55.
1998: L Lecomte-Raclet; M Alemany; A Sequira-Le Grand; Jean Amiral; G Quentin; Anne Marie Vissac; Jacques Caen; ZC Han
New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides.
Blood 1998;91(8):2772-80.
1998: L Lecomte-Raclet; S Aidoudi; I Lebeurier; Claire Bal dit Sollier; G Kishtoo; J F Aubert; Jacques Caen; ZC Han
Quantitation of megakaryocytopoiesis by computerized automatic in culture image analysis.
Platelets 1998;9(2):121-7.
1997: S Aïdoudi; I Lebeurier; Jean Amiral; G Quentin; Jacques Caen; ZC Han
A 13-24 C-terminal peptide related to PF4 accelerates hematopoietic recovery of progenitor cells in vivo in mice treated with 5-fluorouracil.
International journal of hematology 1997;66(4):435-44.
1997: Sylvia Bellucci; ZC Han; Jacques Caen
[Effects of heparin on megakaryocytopoiesis. From fundamental data to clinical applications].
Annales de médecine interne 1997;148(2):150-3.
1996: S Aidoudi; M Guigon; I Lebeurier; Jacques Caen; ZC Han
In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil.
British journal of haematology 1996;94(3):443-8.
1996: ZC Han; Sylvia Bellucci; Z X Shen; J P Maffrand; M Pascal; Maurice Petitou; JC Lormeau; Jacques Caen
Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators.
Journal of cellular physiology 1996;168(1):97-104.
1996: X Xi; Jacques Caen; S Fournier; N Schlegel; Jean Amiral; O Sibony; P Blot; ZC Han
Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: comparative studies with transforming growth factor beta1.
British journal of haematology 1996;93(2):265-72.
1996: A M Maurer; ZC Han; D Dhermy; Jean Briere
Inhibitory effect of platelet factor 4 on human erythroleukemic cells is dependent on cell surface heparan sulfate.
The Journal of laboratory and clinical medicine 1996;127(4):382-90.
1996: I Lebeurier; L Raclet; Jean Amiral; Jacques Caen; ZC Han
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines.
The Journal of laboratory and clinical medicine 1996;127(2):179-85.
1996: I Lebeurier; N Basara; S Aïdoudi; Jean Amiral; Jacques Caen; ZC Han
Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin.
British journal of haematology 1996;92(1):29-34.
1995: ZC Han; X J Zhang; X D Xi; M Lu; S Jiang; L Z Jiang; X M Wang; G L Gu; J P Caen
[Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].
Shi yan sheng wu xue bao 1995;28(4):415-26.
1995: Jacques Caen; X Xi; S Aidoudi; S Fournier; N Schlegel; Sylvia Bellucci; ZC Han
[Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
Bulletin de l'Académie nationale de médecine 1995;179(8):1657-70.
1995: X F Gu; Andreas Bikfalvi; Y Z Chen; Jacques Caen; ZC Han
Constitutive and selective expression of basic fibroblast growth factor in human leukaemia cell lines.
European journal of haematology 1995;55(3):189-94.
1995: X Xi; N Schlegel; Jacques Caen; A Minty; S Fournier; D Caput; Pascual Ferrara; ZC Han
Differential effects of recombinant human interleukin-13 on the in vitro growth of human haemopoietic progenitor cells.
British journal of haematology 1995;90(4):921-7.
1995: Z X Shen; J M Li; Z Y Wang; ZC Han; Jacques Caen; Sylvia Bellucci
Thrombocytopoietic effect of heparin given in chronic immune thrombocytopenic purpura.
Lancet 1995;346(8969):220-1.
1994: A M Maurer; ZC Han; D Dhermy; J Brière
Glycosaminoglycans enhance human leukemic cell growth in vitro.
Leukemia research 1994;18(11):837-42.
1994: Z X Shen; N Basara; X D Xi; Jacques Caen; J P Maffrand; M Pascal; Maurice Petitou; JC Lormeau; ZC Han
Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice.
British journal of haematology 1994;88(3):608-12.
1994: Y Z Chen; X F Gu; Jacques Caen; ZC Han
Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells.
British journal of haematology 1994;88(3):481-7.
1994: ZC Han
Identification of a murine high-proliferative-potential colony-forming cell (HPP-CFC) capable of producing a number of megakaryocytes and replating for secondary HPP-CFCs in culture.
The Journal of laboratory and clinical medicine 1994;123(4):610-6.
1994: Andreas Bikfalvi; ZC Han
Angiogenic factors are hematopoietic growth factors and vice versa.
Leukemia 1994;8(3):523-9.
1993: X F Gu; A Allain; L Li; Elisabeth M Cramer; D Tenza; Jacques Caen; ZC Han
[Expression of cyclin B in megakaryocytes and cells of other hematopoietic lines].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(12):1438-45.
1993: Jacques Caen; ZC Han
Control of megakaryocyte development: from basic data to clinical results.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(9):919-30.
1993: ZC Han; Jacques Caen
Are megakaryocytes and endothelial cells sisters?
The Journal of laboratory and clinical medicine 1993;121(6):821-5.
1992: Andreas Bikfalvi; ZC Han; G Fuhrmann
Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells.
Blood 1992;80(8):1905-13.
1992: ZC Han; A M Maurer; Sylvia Bellucci; H Y Wan; Y Kroviarski; O Bertrand; Jacques Caen
Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.
The Journal of laboratory and clinical medicine 1992;120(4):645-60.
1992: ZC Han; Andreas Bikfalvi; Z X Shen; E Bodevin
Recombinant acidic human fibroblast growth factor (aFGF) stimulates murine megakaryocyte colony formation in vitro.
International journal of hematology 1992;55(3):281-6.
1992: Sylvia Bellucci; ZC Han; Dominique Pidard; Jacques Caen
Identification of a normal human bone marrow cell population co-expressing megakaryocytic and erythroid markers in culture.
European journal of haematology 1992;48(5):259-65.
1992: ZC Han; Sylvia Bellucci; H Y Wan; Jacques Caen
New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1.
British journal of haematology 1992;81(1):1-5.
1991: ZC Han; Sylvia Bellucci; Jacques Caen
Megakaryocytopoiesis: characterization and regulation in normal and pathologic states.
International journal of hematology 1991;54(1):3-14.
1991: ZC Han; Sylvia Bellucci; E Bodevin; H Y Wan; Z X Shen; Jacques Caen
In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1991;313(12):553-8.
1991: Jacques Caen; ZC Han; Sylvia Bellucci
Growth and differentiation factors in megakaryocytopoiesis.
Nouvelle revue française d'hématologie 1991;33(2):165-7.
1990: ZC Han; Sylvia Bellucci; A Walz; M Baggiolini; Jacques Caen
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III).
International journal of cell cloning 1990;8(4):253-9.
1990: ZC Han; Sylvia Bellucci; D Tenza; Jacques Caen
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura.
British journal of haematology 1990;74(4):395-401.
1990: ZC Han; Sylvia Bellucci; Jacques Caen
Regulation of human megakaryocytopoiesis.
Nouvelle revue française d'hématologie 1990;32(6):395-6.